Hospital General Universitario de Albacete; Servicio de Neurología
About Hospital General Universitario de Albacete; Servicio de Neurología
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Hospital General Universitario de Albacete; Servicio de Neurología
During the past decade, Hospital General Universitario de Albacete; Servicio de Neurología conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital General Universitario de Albacete; Servicio de Neurología
According to Clinical.Site data, the most researched conditions in "Hospital General Universitario de Albacete; Servicio de Neurología" are
"Alzheimer Disease" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Hospital General Universitario de Albacete; Servicio de Neurología" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General Universitario de Albacete; Servicio de Neurología
Most popular intervention types in "Hospital General Universitario de Albacete; Servicio de Neurología" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Gantenerumab" (2 trials), "Placebo" (2 trials) and "Crenezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General Universitario de Albacete; Servicio de Neurología
The vast majority of trials in "Hospital General Universitario de Albacete; Servicio de Neurología" are
3 trials for "All" genders.
Clinical Trials Status at Hospital General Universitario de Albacete; Servicio de Neurología
Currently, there are NaN active trials in "Hospital General Universitario de Albacete; Servicio de Neurología".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Hospital General Universitario de Albacete; Servicio de Neurología,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General Universitario de Albacete; Servicio de Neurología, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".